In its 2024 Global Cancer Statistics report, the American Cancer Society has brought attention ... plan that includes pharmaceutical products. GSK plc (NYSE:GSK) specializes in pharmaceuticals ...

according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...

GSK isn't revealing the size of the OS improvement yet – it has promised to do so at the American Society for Haematology ... At this year's ASCO cancer congress in February, earlier results ...

American Cancer Society is highlighting its CancerRisk360 assessment tool in response to an increase in colorectal cancer cases among younger individuals.

The results were featured at the American Society of Haematology (ASH) annual meeting and, according to GSK, "support the potential ... treatment for the blood cancer. After being all but written ...

The British biopharmaceutical company GlaxoSmithKline Plc (GSK) has entered into an agreement ... with offices in 150 countries. IDRx is an American biopharmaceutical company developing cancer ...

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...